We present the case of catastrophic antiphospholipid syndrome occurring in a 44-year-old woman with a recent history of coronary artery bypass surgery. Postoperatively, she was urgently readmitted for a left middle cerebral artery stroke, and during workup she was found with a left ventricular thrombus on echocardiogram. Subsequently, the patient was diagnosed with antiphospholipid syndrome. Multimodality imaging, including bone and myocardial perfusion scintigraphy, CT, and MR, during her hospitalization, depicted all the characteristic features constituting the catastrophic form of antiphospholipid syndrome, also known as Asherson syndrome.
F, Brain MR examination shows the left cerebral infarction with edema (arrows). The chain of successive clinical events experienced by the patient and depicted by the multimodality imaging in a short period of time was consistent with catastrophic antiphospholipid syndrome (CAPS). Antiphospholipid syndrome (APS) or Hughes syndrome is an autoimmune disease that affects the blood ability to clot, resulting in arterial and/or venous thrombosis, which can cause multiorgan infarcts. 1, 2 The condition is a result of an overproduction of antiphospholipid antibodies, which bind to phospholipid-binding proteins, causing thrombosis. 3 Catastrophic APS, also known as Asherson syndrome and accounting for less than 1% of APS, is the most severe and potentially lethal form. 4, 5 Catastrophic APS may also occur in patients with systemic lupus erythematosus, lupuslike diseases, and other autoimmune disorders. Triggering factors of CAPS include infections, surgical procedures, anticoagulant withdrawal, obstetrical complications, neoplasia, and systemic lupus erythematosus flares. It is associated with a rapid development of microvascular thrombosis resulting in multiorgan infarcts and failure despite anticoagulant therapy. 6 Manifestations of CAPS encompass acute respiratory distress syndrome, infarction or failure of heart and intra-abdominal organs, neurological complications, vascular thrombosis, skin lesions such as ecchymosis, livedo reticularis, ulcer and gangrene, and bone marrow necrosis. [6] [7] [8] [9] The high mortality of CAPS may be lessened with a combined therapy of anticoagulants, corticosteroids, plasma exchange, and intravenous immunoglobulins.
